Leadership

As BeiGene Canada’s General Manager, Peter Brenders is responsible for building and leading Canadian affiliate operations, strategic planning, cross-functional teams, and driving domestic growth opportunities making new and innovative oncology therapies accessible and affordable to Canadians in need.

A seasoned and award-winning leader, Peter is passionate about patient-centered care with specific expertise in the areas of hematology, oncology, neurology, and rare diseases.  For over two decades he has driven strategic partnerships and growth in the digital and life sciences sectors

In addition to holding an MBA in Health Services Management, Peter has executive education from the Stanford Graduate School of Business, the Harvard Business School and Queen’s University. He has held various board and advisory roles at university-affiliated research institutions, not-for-profit organizations, and for-profit businesses, and currently serves on the advisory board of the clinical research unit of the Montreal Neurological Institute.

As BeiGene Canada’s Commercial Lead, Hematology, Andrea Schwarz is responsible for overseeing sales and marketing, as well as the Patient Support Program (PSP) for the hematology product portfolio. A results-oriented leader with over a decade of experience in commercial leadership roles, Andrea has a track record of building high-performing teams to successfully deliver therapies and digital healthcare innovations to patients across Canada.

Prior to joining BeiGene, Andrea served as Director of Sales at TELUS for its Health Care Centres. She has also held Associate Director of Sales positions in immunology.  Andrea is a member of the Women Leaders in Pharma Executive Team where she coaches and mentors women as a certified International Coaching Federation (ICF) professional coach.

Jason Bonnyman brings over twenty years of pharmaceutical industry experience, specifically in the areas of oncology and hematology, to his role as Commercial Lead, Solid Tumor.  As a member of BeiGene Canada’s leadership team, Jason plays a key role in overseeing and building BeiGene’s commercial footprint in Canada.

Having assumed multiple sales and marketing leadership positions, Jason has developed broad expertise in complex environments, including various areas of solid and liquid tumors.  Jason has worked closely with cancer and healthcare stakeholders to successfully bring products to the Canadian market and is passionate about bringing innovation and hope to patients.

As Senior Director, Value Access & Policy, Nathalie Desrosiers leads overall market access strategy in Canada including patient advocacy, reimbursement, health policy and government affairs. A key member of BeiGene Canada’s leadership team, Nathalie partners closely with all functional areas playing a key role in helping to optimize patient access and support business development activities.

With expertise in the areas of health economics, outcomes research, clinical research and health policy, Nathalie has assumed leadership roles related to patient access in the oncology space. She holds a Master of Science Degree in Immunology and Virology from the National Institute of Scientific Research of Montreal and a Doctor of Philosophy Degree from McGill University.

With over two decades of experience in the Canadian pharmaceutical industry, specifically in clinical oncology biotechnology, Country Medical Director and scientific lead, Brad Gillesby, oversees the design and implementation of BeiGene Canada’s medical affairs strategy and plays a key role in investigator-initiated research and clinical activities.

A Ph.D in Pharmacology and Toxicology with a specialization in Molecular Biology from Western University, Brad has extensive knowledge of the Canadian regulatory environment. Areas of expertise also include clinical research, health economics, strategic leadership, and corporate medical governance.

Senior Director of Regulatory Affairs, Sharon Safranyos is responsible for developing, implementing, and advising on global regulatory strategies at BeiGene Canada. Sharon plays a leading role in interacting with Health Canada, anticipating future market dynamics, and ensuring the scientific integrity of sponsored and supported research. With over 20 years of experience as a regulatory affairs professional, she has demonstrated expertise in leadership, negotiations, and product approvals along with extensive knowledge of the highly regulated Canadian healthcare environment.

Sharon started her career in the UK as a Medical Laboratory Scientist in Haematology and Blood Transfusion, with a Fellowship in Transfusion Medicine. She then transitioned into Regulatory Affairs and has spent over 20 years in Regulatory and Quality, both in corporate and as a Senior Consultant.

Blair Dugan, BeiGene’s Senior Director, Human Resources, is responsible for leading the Global Talent Acquisition team and serves as the HR Business Partner to both the Commercial and Medical Affairs groups.

Blair brings over fifteen years of experience building high-performance teams in the biotechnology industry and specifically in the oncology space.  Since joining BeiGene, she has scaled the organization from 250 employees to over 10,000 globally and is passionate about supporting teams in reaching their potential to best serve patients.  Blair holds a Bachelor of Business Administration from California State University.

As BeiGene’s Senior Director Compliance, Ashley Riley supports the development and implementation of the Global Healthcare Compliance Program with a specific focus on U.S. and Canadian operations. Ashley is a trusted partner to cross-functional teams supporting on planning and strategy for pipeline indications and products.

Previously, Ashley held life science consulting roles over the course of the past 10 years advising and supporting small, midsize, and large organizations with the design, implementation, and enhancement of their compliance programs. Ashley earned her J.D. from the Elon University School of Law in North Carolina.

As BeiGene’s Senior Franchise Counsel, Alexander Koutrouvelis is a trusted legal advisor to various cross-functional teams. Alex brings over twenty years of experience supporting on complex legal issues in the life sciences space and has spent his career providing counsel related to the launch of oncology products and clinical research programs. Alex holds a Bachelor of Arts in International Relations from the University of Virginia and obtained his law degree from Saint Louis University.

As BeiGene Canada’s Finance Lead, César plays a critical role supporting the team improving our financial process, implementing new tools and bringing more transparency to further consolidate the Financial Discipline across the commercial and medical affairs teams.

César brings over 13 years of Financial Planning and Analysis experience in the Pharmaceutical Industry. Most recently, César was Senior Manager, FP&A for Abbott Laboratories where he optimized the planning, forecasting and analytics processes, partnering with regional and corporate leaders implementing new tools and dashboards providing valuable insights for the business. Before Abbott, César worked at Novartis in various Finance roles of increasing responsibility in Mexico and the US.